Could a shorter, gentler treatment beat a deadly blood cancer?
NCT ID NCT07407660
Summary
This study is testing if a shorter course of a common leukemia drug combination is as effective as the standard longer course for older or frail patients. Researchers want to see if stopping the drug early for patients who respond quickly can reduce severe side effects like infections and low blood counts, without hurting treatment success. The trial will enroll 250 newly diagnosed patients who cannot tolerate intense chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.